What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?

Two drugs, two different destinies. Does their story prove that business practice makes the difference?

The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

Sitting Down With… Gen Li, CEO, Phesi

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?

Water is the giver of life, but could it be a giver of untold medicines too?